Why we need a sector-wide emphasis on accessible health informationIn the quest to provide evidence-based health information, the importance of understandable, accessible materials can get lost in Share XWhy we need a sector-wide emphasis on accessible health informationhttps://pharmaphorum.com/views-analysis-patients/why-we-need-a-sector-wide-emphasis-on-accessible-health-information/
Bridging the gap between industry and charities: Enabling PPI in researchPublic and patient involvement (PPI) in clinical research is the new normal, but bridging the gap between how Share XBridging the gap between industry and charities: Enabling PPI in researchhttps://pharmaphorum.com/views-analysis-patients/bridging-the-gap-between-industry-and-charities-enabling-ppi-in-research/
From supplier to partner – how industry can work better with the new-look NHSA move towards integrated care systems (ICS), complete with new primary care roles, and a greater focus on Share XFrom supplier to partner – how industry can work better with the new-look NHShttps://pharmaphorum.com/views-analysis-market-access/from-supplier-to-partner-how-industry-can-work-better-with-the-new-look-nhs/
Unlocking the gut microbiome’s secretsEvery decade or so science finds a new mountain to climb, and the gut microbiome is our latest Share XUnlocking the gut microbiome’s secretshttps://pharmaphorum.com/r-d/views-analysis-r-d/unlocking-the-gut-microbiomes-secrets/
Towards patient centricity: GSKEmbedding the patient voice into the DNA of a pharmaceutical company isn’t easy – but it is essential. Share XTowards patient centricity: GSKhttps://pharmaphorum.com/patients/towards-patient-centricity-gsk/
Transforming oncology with a pan-European approach to data sharingBetween genomic data, electronic health records and digital health tools, we have all the information we need to Share XTransforming oncology with a pan-European approach to data sharinghttps://pharmaphorum.com/views-analysis-oncology/transforming-oncology-with-a-pan-european-approach-to-data-sharing/
Removing logistical barriers to improve clinical trial retentionWe all know how long and arduous the clinical trial road is for sites and sponsors – but Share XRemoving logistical barriers to improve clinical trial retentionhttps://pharmaphorum.com/views-analysis-patients/removing-logistical-barriers-to-improve-clinical-trial-retention/
Towards patient centricity: PfizerIn a new series Amanda Barrell looks at how different companies are turning patient centricity into a reality. Share XTowards patient centricity: Pfizerhttps://pharmaphorum.com/views-and-analysis/towards-patient-centricity-pfizer/
Listening to the patient voice: Why developing new dementia treatments is everyone’s jobDeveloping life-changing treatments for dementia is a team effort that takes commitment from all involved, from charities and Share XListening to the patient voice: Why developing new dementia treatments is everyone’s jobhttps://pharmaphorum.com/views-and-analysis/listening-to-the-patient-voice-why-developing-new-dementia-treatments-is-everyones-job/
